Scienture Holdings, Inc. (SCNX)

Listed in the US · Manufacturing · Pharmaceutical preparations

$3.49

As of 29 Oct 2026 close.

Facts from reported results and exchange filings. Not investment advice.

Share price

Prices load here as you scroll to them.

Last close $3.49 on 29 Oct 2026. The share price traded between $2.64 and $27.75 (intraday) over the last 12 months.

The closes as a table

DateClose

Key figures

1-year range (intraday)

Last close $3.49

Low $2.64High $27.75

Market cap$143Mlast close × shares
Net profit−$37.95Mlast 12 months
Return on equity−59.2%year to Dec 2025
EBITDA marginn/myear to Dec 2025
Net marginn/myear to Dec 2025

P/E isn't shown: the company made a loss over the last 12 months, and a loss has no P/E.

Revenue is very small next to this company's costs or profit, so its margins here are extreme figures (beyond ±100%). They are what the reported numbers give, but they say little about how the business earns.

Price trend

Revenue and profit

RevenueNet profit$ million
-60-40-20020
YearDec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Revenue9.8910.251.360.140.43
Net profit-5.32-3.47-17.849.07-41.51
EBITDA margin-53.4%-28.3%-320.9%n/mn/m
Borrowings–––2.90–

$ million. Over three years, compounded: revenue fell 65.3% a year.

Recent filings

Questions about Scienture Holdings, Inc.

What is Scienture Holdings, Inc.'s market value?

Scienture Holdings, Inc.'s market value is $143M as of 29 Oct 2026 close: the last close times the shares in issue.

Go further with SCNX

Free to start: test a trading idea on SCNX's real prices after costs, or open the full deep dive with ten years of numbers, red flags and management's record.

Same industry

The largest companies in the same industry (Pharmaceutical preparations), by market value.

Browse companies

The companies before and after this one, A to Z, and the lists it is in.

How these figures are worked out

The net profit for the last 12 months is the four latest reported quarters, so it can differ from the newest year's in the table below.